Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adrenocortical Carcinoma × tipifarnib × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hepatoblastoma 1 Head and Neck Neoplasms 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1

Interventions

Specimen Handling 4 Magnetic Resonance Spectroscopy 4 pembrolizumab 3 Nivolumab 3 cabozantinib 2 Ipilimumab 2 relacorilant 1 lenvatinib 1 fludarabine phosphate 1 cemiplimab 1 Interleukin-13 1 Fluorodeoxyglucose F18 1 Floxuridine 1 E-7386 1 Dexamethasone 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡